A hearing will get underway in Delaware later today in the latest phase of GSK’s attempts to defend itself from allegations that its Zantac drug caused cancer in patients. The three-day hearing ...

Another jury in the same courthouse handed a verdict last month to a separate Zantac manufacturer, GlaxoSmithKline. On May 23, an Illinois jury sided with both drug manufacturers in the first ...

Hung jury in latest Zantac cancer trial in Chicago Boehringer Ingelheim only defendant after settlements with GSK, Pfizer FDA pulled Zantac in 2020 over NDMA carcinogen concerns Sept 18 (Reuters ...

GSK and other drugmakers fending off litigation claiming that gastrointestinal drug Zantac or a generic caused cancer have won a supreme court ruling in Canada, after also chalking up wins in the US.

Twelve days after GSK secured a key win in Florida, with a state court tossing expert testimony on the cancer-causing potential of heartburn drug Zantac (ranitidine), the British company has ...

Sep. 11, 2024 — A technology which uses harmless light waves to measure activity in babies' brains has provided the most complete picture to date of brain functions ... Babies Born to Women ...

Boehringer Ingelheim, GSK, Pfizer and Sanofi all sold brand name Zantac at various times since it was approved in 1983, and have been named in tens of thousands of lawsuits over the alleged cancer ...

(Reuters) – The latest trial over claims that the discontinued heartburn drug Zantac causes cancer ended with a hung jury on Wednesday, as jurors in Chicago were unable to agree on whether ...

An Illinois mistrial involving the recalled medication Zantac is the latest court decision involving the recalled drug, but won’t be the last. A juror’s note—"I must leave. This has not been resolved" ...

The companies, which also include Pfizer and Sanofi, are challenging a lower court ruling that allowed expert testimony claiming Zantac causes cancer – a link they say is not credible.

However, it has been stated that the palatability to infants of the alcoholic colecalciferol preparation is poor. Methods: In an ambulatory care setting, the palatability of two liquid ...

The litigation at the center of this legal battle revolves around allegations that ranitidine, the active ingredient in Zantac, may be linked to an increased risk of cancer. “In our view ...